"Enormous progress has been made in tumor immunology and the results have been translated into clinical research during the last two decades. Antibody therapy is now part of routine clinical care for a lot of malignant diseases and cancer vaccines will be established as an integrated part of the therapeutic arsenals during the coming 10 years. Immunology has come to stay in oncology. This EIS meeting will give you the recent up-dates in oncological immunotherapy."

Håkan Mellstedt, Sweden
ESMO President

"The increasing knowledge about the way the immune system functions is leading to exciting new therapeutic possibilities for cancer patients. This Symposium will provide young cancer specialists with a comprehensive overview of the interaction between the immune system and cancer."